TY  - GEN
AU  - Li,Yiwen
AU  - Takemura,Genzou
AU  - Okada,Hideshi
AU  - Miyata,Shusaku
AU  - Maruyama,Rumi
AU  - Esaki,Masayasu
AU  - Kanamori,Hiromitsu
AU  - Li,Longhu
AU  - Ogino,Atsushi
AU  - Ohno,Takamasa
AU  - Kondo,Takehito
AU  - Nakagawa,Munehiro
AU  - Minatoguchi,Shinya
AU  - Fujiwara,Takako
AU  - Fujiwara,Hisayoshi
TI  - Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure
SN  - 1532-8414
PY  - 2007///0508
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - therapeutic use
KW  - Animals
KW  - Antihypertensive Agents
KW  - Blood Urea Nitrogen
KW  - Blotting, Western
KW  - Creatinine
KW  - blood
KW  - DNA
KW  - genetics
KW  - Disease Models, Animal
KW  - Heart Failure
KW  - drug therapy
KW  - Immunohistochemistry
KW  - Kidney Failure, Chronic
KW  - complications
KW  - Male
KW  - Matrix Metalloproteinase 2
KW  - biosynthesis
KW  - Matrix Metalloproteinase 9
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Myocardium
KW  - metabolism
KW  - Nephrectomy
KW  - adverse effects
KW  - Oxidative Stress
KW  - Receptor, Angiotensin, Type 1
KW  - Signal Transduction
KW  - physiology
KW  - Tetrazoles
KW  - Tissue Inhibitor of Metalloproteinase-1
KW  - Transforming Growth Factor beta1
KW  - Treatment Outcome
KW  - Up-Regulation
KW  - drug effects
KW  - Valine
KW  - analogs & derivatives
KW  - Valsartan
KW  - Ventricular Function, Left
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.cardfail.2006.11.005
ER  -